307 related articles for article (PubMed ID: 33723056)
1. Decoupling expression and editing preferences of ADAR1 p150 and p110 isoforms.
Sun T; Yu Y; Wu X; Acevedo A; Luo JD; Wang J; Schneider WM; Hurwitz B; Rosenberg BR; Chung H; Rice CM
Proc Natl Acad Sci U S A; 2021 Mar; 118(12):. PubMed ID: 33723056
[TBL] [Abstract][Full Text] [Related]
2. RNA editing at a limited number of sites is sufficient to prevent MDA5 activation in the mouse brain.
Kim JI; Nakahama T; Yamasaki R; Costa Cruz PH; Vongpipatana T; Inoue M; Kanou N; Xing Y; Todo H; Shibuya T; Kato Y; Kawahara Y
PLoS Genet; 2021 May; 17(5):e1009516. PubMed ID: 33983932
[TBL] [Abstract][Full Text] [Related]
3. The RNA-editing enzyme ADAR1: a regulatory hub that tunes multiple dsRNA-sensing pathways.
Nakahama T; Kawahara Y
Int Immunol; 2023 Mar; 35(3):123-133. PubMed ID: 36469491
[TBL] [Abstract][Full Text] [Related]
4. Identification of ADAR1 p150 and p110 Associated Edit Sites.
Sun T; Rosenberg BR; Chung H; Rice CM
Methods Mol Biol; 2023; 2651():285-294. PubMed ID: 36892775
[TBL] [Abstract][Full Text] [Related]
5. The adenosine deaminase acting on RNA 1 p150 isoform is involved in the pathogenesis of dyschromatosis symmetrica hereditaria.
Zhang JY; Chen XD; Zhang Z; Wang HL; Guo L; Liu Y; Zhao XZ; Cao W; Xing QH; Shao FM
Br J Dermatol; 2013 Sep; 169(3):637-44. PubMed ID: 23621630
[TBL] [Abstract][Full Text] [Related]
6. The role of RNA editing enzyme ADAR1 in human disease.
Song B; Shiromoto Y; Minakuchi M; Nishikura K
Wiley Interdiscip Rev RNA; 2022 Jan; 13(1):e1665. PubMed ID: 34105255
[TBL] [Abstract][Full Text] [Related]
7. Dyschromatosis Symmetrica Hereditaria and Aicardi-Goutières Syndrome 6 Are Phenotypic Variants Caused by ADAR1 Mutations.
Kono M; Matsumoto F; Suzuki Y; Suganuma M; Saitsu H; Ito Y; Fujiwara S; Moriwaki S; Matsumoto K; Matsumoto N; Tomita Y; Sugiura K; Akiyama M
J Invest Dermatol; 2016 Apr; 136(4):875-878. PubMed ID: 26802932
[No Abstract] [Full Text] [Related]
8. RNA-Editing Enzyme ADAR1 p150 Isoform Is Critical for Germinal Center B Cell Response.
Li Y; Ruan GX; Chen W; Huang H; Zhang R; Wang J; Li Y; Xu S; Ou X
J Immunol; 2022 Sep; 209(6):1071-1082. PubMed ID: 35977796
[TBL] [Abstract][Full Text] [Related]
9. Co-occurrence of Aicardi-Goutières syndrome type 6 and dyschromatosis symmetrica hereditaria due to compound heterozygous pathogenic variants in ADAR1: a case series from India.
Sathishkumar D; Muthusamy K; Gupta A; Malhotra M; Thomas M; Koshy B; Jasper A; Danda S; George R
Clin Exp Dermatol; 2021 Jun; 46(4):704-709. PubMed ID: 33289110
[TBL] [Abstract][Full Text] [Related]
10. RNA editing of AZIN1 coding sites is catalyzed by ADAR1 p150 after splicing.
Xing Y; Nakahama T; Wu Y; Inoue M; Kim JI; Todo H; Shibuya T; Kato Y; Kawahara Y
J Biol Chem; 2023 Jul; 299(7):104840. PubMed ID: 37209819
[TBL] [Abstract][Full Text] [Related]
11. Mutations in the adenosine deaminase ADAR1 that prevent endogenous Z-RNA binding induce Aicardi-Goutières-syndrome-like encephalopathy.
Nakahama T; Kato Y; Shibuya T; Inoue M; Kim JI; Vongpipatana T; Todo H; Xing Y; Kawahara Y
Immunity; 2021 Sep; 54(9):1976-1988.e7. PubMed ID: 34525338
[TBL] [Abstract][Full Text] [Related]
12. Deciphering the Biological Significance of ADAR1-Z-RNA Interactions.
Nakahama T; Kawahara Y
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768866
[TBL] [Abstract][Full Text] [Related]
13. Aicardi-Goutières syndrome-associated mutation at ADAR1 gene locus activates innate immune response in mouse brain.
Guo X; Wiley CA; Steinman RA; Sheng Y; Ji B; Wang J; Zhang L; Wang T; Zenatai M; Billiar TR; Wang Q
J Neuroinflammation; 2021 Jul; 18(1):169. PubMed ID: 34332594
[TBL] [Abstract][Full Text] [Related]
14. [Expression of ADAR1 isoforms in murine acute T-ALL leukemia model].
Ma CH; Tian C; Chong JH; Shi YX; Wang JH; Lin YM; Xu J; Zheng GG
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Jun; 19(3):566-9. PubMed ID: 21729523
[TBL] [Abstract][Full Text] [Related]
15. An RNA editor, adenosine deaminase acting on double-stranded RNA (ADAR1).
George CX; John L; Samuel CE
J Interferon Cytokine Res; 2014 Jun; 34(6):437-46. PubMed ID: 24905200
[TBL] [Abstract][Full Text] [Related]
16. Editing of Cellular Self-RNAs by Adenosine Deaminase ADAR1 Suppresses Innate Immune Stress Responses.
George CX; Ramaswami G; Li JB; Samuel CE
J Biol Chem; 2016 Mar; 291(12):6158-68. PubMed ID: 26817845
[TBL] [Abstract][Full Text] [Related]
17. The ADAR1 editome reveals drivers of editing-specificity for ADAR1-isoforms.
Kleinova R; Rajendra V; Leuchtenberger AF; Lo Giudice C; Vesely C; Kapoor U; Tanzer A; Derdak S; Picardi E; Jantsch MF
Nucleic Acids Res; 2023 May; 51(9):4191-4207. PubMed ID: 37026479
[TBL] [Abstract][Full Text] [Related]
18. Isoforms of RNA-Editing Enzyme ADAR1 Independently Control Nucleic Acid Sensor MDA5-Driven Autoimmunity and Multi-organ Development.
Pestal K; Funk CC; Snyder JM; Price ND; Treuting PM; Stetson DB
Immunity; 2015 Nov; 43(5):933-44. PubMed ID: 26588779
[TBL] [Abstract][Full Text] [Related]
19. Dyschromatosis symmetrica hereditaria and reticulate acropigmentation of Kitamura: An update.
Kono M; Akiyama M
J Dermatol Sci; 2019 Feb; 93(2):75-81. PubMed ID: 30692041
[TBL] [Abstract][Full Text] [Related]
20. Base-pairing probability in the microRNA stem region affects the binding and editing specificity of human A-to-I editing enzymes ADAR1-p110 and ADAR2.
Ishiguro S; Galipon J; Ishii R; Suzuki Y; Kondo S; Okada-Hatakeyama M; Tomita M; Ui-Tei K
RNA Biol; 2018; 15(7):976-989. PubMed ID: 29950133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
